These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29666752)

  • 1. Pathways of topological rank analysis (PoTRA): a novel method to detect pathways involved in hepatocellular carcinoma.
    Li C; Liu L; Dinu V
    PeerJ; 2018; 6():e4571. PubMed ID: 29666752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A personalized approach identifies disturbed pathways and key genes in hepatitis C virus-cirrhosis with hepatocellular carcinoma.
    Li YL; Zheng MX; Wang G
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4266-4273. PubMed ID: 27831648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma.
    Li C; Dinu V
    J Biomed Inform; 2018 May; 81():31-40. PubMed ID: 29578099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equal opportunity for low-degree network nodes: a PageRank-based method for protein target identification in metabolic graphs.
    Bánky D; Iván G; Grolmusz V
    PLoS One; 2013; 8(1):e54204. PubMed ID: 23382878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma.
    Cai C; Wang W; Tu Z
    J Cancer; 2019; 10(2):355-366. PubMed ID: 30719129
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data.
    Zeng Z; Cao Z; Tang Y
    Oncol Lett; 2020 Nov; 20(5):231. PubMed ID: 32968453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodes.
    Singh S; Colonna G; Di Bernardo G; Bergantino F; Cammarota M; Castello G; Costantini S
    Mol Biosyst; 2015 Nov; 11(11):2933-45. PubMed ID: 26267014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.
    Poortahmasebi V; Poorebrahim M; Najafi S; Jazayeri SM; Alavian SM; Arab SS; Ghavami S; Alavian SE; Rezaei Moghadam A; Amiri M
    Hepat Mon; 2016 Feb; 16(2):e36005. PubMed ID: 27148389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub subnetwork based on topological features of genes in breast cancer.
    Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
    Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.
    Liu J; Hua P; Hui L; Zhang LL; Hu Z; Zhu YW
    Exp Ther Med; 2016 Oct; 12(4):2109-2119. PubMed ID: 27703495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing.
    Zheng Y; Long J; Wu L; Zhang H; Li L; Zheng Y; Wang A; Lin J; Yang X; Sang X; Hu K; Pan J; Zhao H
    Oncotarget; 2017 Sep; 8(36):60358-60367. PubMed ID: 28947976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative module analysis of HCC gene expression landscapes.
    Li H; Wei N; Ma Y; Wang X; Zhang Z; Zheng S; Yu X; Liu S; He L
    Exp Ther Med; 2020 Mar; 19(3):1779-1788. PubMed ID: 32104233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Pathways and Genes in the Dynamic Progression of HCC Based on WGCNA.
    Yin L; Cai Z; Zhu B; Xu C
    Genes (Basel); 2018 Feb; 9(2):. PubMed ID: 29443924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes.
    Bidkhori G; Benfeitas R; Klevstig M; Zhang C; Nielsen J; Uhlen M; Boren J; Mardinoglu A
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11874-E11883. PubMed ID: 30482855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
    Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
    Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network.
    Lu D; Bai X; Zou Q; Gan Z; Lv Y
    Oncol Lett; 2020 Sep; 20(3):2645-2654. PubMed ID: 32765791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.